Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer
Abstract. Background:. Bladder cancer, characterized by a high potential of tumor recurrence, has high lifelong monitoring and treatment costs. To date, tumor cells with intrinsic softness have been identified to function as cancer stem cells in several cancer types. Nonetheless, the existence of s...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2024-01-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002710 |
_version_ | 1797352764298231808 |
---|---|
author | Shi Qiu Yaqi Qiu Linghui Deng Ling Nie Liming Ge Xiaonan Zheng Di Jin Kun Jin Xianghong Zhou Xingyang Su Boyu Cai Jiakun Li Xiang Tu Lina Gong Liangren Liu Zhenhua Liu Yige Bao Jianzhong Ai Tianhai Lin Lu Yang Qiang Wei Jinjiao Li Yuanyuan Ji |
author_facet | Shi Qiu Yaqi Qiu Linghui Deng Ling Nie Liming Ge Xiaonan Zheng Di Jin Kun Jin Xianghong Zhou Xingyang Su Boyu Cai Jiakun Li Xiang Tu Lina Gong Liangren Liu Zhenhua Liu Yige Bao Jianzhong Ai Tianhai Lin Lu Yang Qiang Wei Jinjiao Li Yuanyuan Ji |
author_sort | Shi Qiu |
collection | DOAJ |
description | Abstract.
Background:. Bladder cancer, characterized by a high potential of tumor recurrence, has high lifelong monitoring and treatment costs. To date, tumor cells with intrinsic softness have been identified to function as cancer stem cells in several cancer types. Nonetheless, the existence of soft tumor cells in bladder tumors remains elusive. Thus, our study aimed to develop a micro-barrier microfluidic chip to efficiently isolate deformable tumor cells from distinct types of bladder cancer cells.
Methods:. The stiffness of bladder cancer cells was determined by atomic force microscopy (AFM). The modified microfluidic chip was utilized to separate soft cells, and the 3D Matrigel culture system was to maintain the softness of tumor cells. Expression patterns of integrin β8 (ITGB8), protein kinase B (AKT), and mammalian target of rapamycin (mTOR) were determined by Western blotting. Double immunostaining was conducted to examine the interaction between F-actin and tripartite motif containing 59 (TRIM59). The stem-cell-like characteristics of soft cells were explored by colony formation assay and in vivo studies upon xenografted tumor models.
Results:. Using our newly designed microfluidic approach, we identified a small fraction of soft tumor cells in bladder cancer cells. More importantly, the existence of soft tumor cells was confirmed in clinical human bladder cancer specimens, in which the number of soft tumor cells was associated with tumor relapse. Furthermore, we demonstrated that the biomechanical stimuli arising from 3D Matrigel activated the F-actin/ITGB8/TRIM59/AKT/mTOR/glycolysis pathways to enhance the softness and tumorigenic capacity of tumor cells. Simultaneously, we detected a remarkable up-regulation in ITGB8, TRIM59, and phospho-AKT in clinical bladder recurrent tumors compared with their non-recurrent counterparts.
Conclusions:. The ITGB8/TRIM59/AKT/mTOR/glycolysis axis plays a crucial role in modulating tumor softness and stemness. Meanwhile, the soft tumor cells become more sensitive to chemotherapy after stiffening, that offers new insights for hampering tumor progression and recurrence. |
first_indexed | 2024-03-08T13:21:36Z |
format | Article |
id | doaj.art-556515df523e49debcd53e88748a58ff |
institution | Directory Open Access Journal |
issn | 0366-6999 2542-5641 |
language | English |
last_indexed | 2024-03-08T13:21:36Z |
publishDate | 2024-01-01 |
publisher | Wolters Kluwer |
record_format | Article |
series | Chinese Medical Journal |
spelling | doaj.art-556515df523e49debcd53e88748a58ff2024-01-18T03:06:13ZengWolters KluwerChinese Medical Journal0366-69992542-56412024-01-01137220922110.1097/CM9.0000000000002710202401200-00010Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancerShi Qiu0Yaqi Qiu1Linghui Deng2Ling Nie3Liming Ge4Xiaonan Zheng5Di Jin6Kun Jin7Xianghong Zhou8Xingyang Su9Boyu Cai10Jiakun Li11Xiang Tu12Lina Gong13Liangren Liu14Zhenhua Liu15Yige Bao16Jianzhong Ai17Tianhai Lin18Lu Yang19Qiang Wei20Jinjiao LiYuanyuan Ji1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China3 Department of Science and Drug Technology, University of Turin, Turin, Italy4 National Clinical Research Center of Geriatrics, The Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China5 Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China6 Department of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610000, China.1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China1 Department of Urology, Institute of Urology, National Clinical Research Center for Geriatrics and Center of Biomedical Big Data, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, ChinaAbstract. Background:. Bladder cancer, characterized by a high potential of tumor recurrence, has high lifelong monitoring and treatment costs. To date, tumor cells with intrinsic softness have been identified to function as cancer stem cells in several cancer types. Nonetheless, the existence of soft tumor cells in bladder tumors remains elusive. Thus, our study aimed to develop a micro-barrier microfluidic chip to efficiently isolate deformable tumor cells from distinct types of bladder cancer cells. Methods:. The stiffness of bladder cancer cells was determined by atomic force microscopy (AFM). The modified microfluidic chip was utilized to separate soft cells, and the 3D Matrigel culture system was to maintain the softness of tumor cells. Expression patterns of integrin β8 (ITGB8), protein kinase B (AKT), and mammalian target of rapamycin (mTOR) were determined by Western blotting. Double immunostaining was conducted to examine the interaction between F-actin and tripartite motif containing 59 (TRIM59). The stem-cell-like characteristics of soft cells were explored by colony formation assay and in vivo studies upon xenografted tumor models. Results:. Using our newly designed microfluidic approach, we identified a small fraction of soft tumor cells in bladder cancer cells. More importantly, the existence of soft tumor cells was confirmed in clinical human bladder cancer specimens, in which the number of soft tumor cells was associated with tumor relapse. Furthermore, we demonstrated that the biomechanical stimuli arising from 3D Matrigel activated the F-actin/ITGB8/TRIM59/AKT/mTOR/glycolysis pathways to enhance the softness and tumorigenic capacity of tumor cells. Simultaneously, we detected a remarkable up-regulation in ITGB8, TRIM59, and phospho-AKT in clinical bladder recurrent tumors compared with their non-recurrent counterparts. Conclusions:. The ITGB8/TRIM59/AKT/mTOR/glycolysis axis plays a crucial role in modulating tumor softness and stemness. Meanwhile, the soft tumor cells become more sensitive to chemotherapy after stiffening, that offers new insights for hampering tumor progression and recurrence.http://journals.lww.com/10.1097/CM9.0000000000002710 |
spellingShingle | Shi Qiu Yaqi Qiu Linghui Deng Ling Nie Liming Ge Xiaonan Zheng Di Jin Kun Jin Xianghong Zhou Xingyang Su Boyu Cai Jiakun Li Xiang Tu Lina Gong Liangren Liu Zhenhua Liu Yige Bao Jianzhong Ai Tianhai Lin Lu Yang Qiang Wei Jinjiao Li Yuanyuan Ji Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer Chinese Medical Journal |
title | Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer |
title_full | Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer |
title_fullStr | Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer |
title_full_unstemmed | Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer |
title_short | Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer |
title_sort | cell softness reveals tumorigenic potential via itgb8 akt glycolysis signaling in a mice model of orthotopic bladder cancer |
url | http://journals.lww.com/10.1097/CM9.0000000000002710 |
work_keys_str_mv | AT shiqiu cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT yaqiqiu cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT linghuideng cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT lingnie cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT limingge cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT xiaonanzheng cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT dijin cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT kunjin cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT xianghongzhou cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT xingyangsu cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT boyucai cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT jiakunli cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT xiangtu cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT linagong cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT liangrenliu cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT zhenhualiu cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT yigebao cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT jianzhongai cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT tianhailin cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT luyang cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT qiangwei cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT jinjiaoli cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer AT yuanyuanji cellsoftnessrevealstumorigenicpotentialviaitgb8aktglycolysissignalinginamicemodeloforthotopicbladdercancer |